Trial Search Results
Phase II Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)
A research study using a method of treating lung cancer with focused radiation called Stereotactic Ablative Radiotherapy (SABR). The purpose of this study is to evaluate the effectiveness of individualizing the dose of radiation used to treat lung tumors with SABR based on tumor-specific factors.
Stanford is currently not accepting patients for this trial.